Medicinal chemistry perspective on the structure–activity relationship of stilbene derivatives
Open Access
- 18 June 2024
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (28) , 19823-19879
Abstract
Stilbenes are a small family of polyphenolic secondary metabolites produced in a variety of closely related plant species. These compounds function as phytoalexins, aiding plant defense against phytopathogens and plants' adaptation to abiotic environmental factors. Structurally, some important phenolic compounds have a 14-carbon skeleton and usually have two isomeric forms, Z and E. Stilbenes contain two benzene rings linked by a molecule of ethanol or ethylene. Some derivatives of natural (poly)phenolic stilbenes such as resveratrol, pterostilbene, and combretastatin A-4 have shown various biological activities, such as anti-microbial, anti-cancer, and anti-inflammatory properties as well as protection against heart disease, Alzheimer's disease, and diabetes. Among stilbenes, resveratrol is certainly the most popular and extensively studied for its health properties. In recent years, an increasing number of stilbene compounds have been investigated for their bioactivity. This review focuses on the assessment of synthetic stilbene derivatives in terms of their biological activities and structure–activity relationship. The goal of this study is to consider the structural changes and different substitutions on phenyl rings that can improve the desired medicinal effects of stilbene-based compounds beyond the usual standards and subsequently discover biological activities by identifying effective alternatives of the evaluated compounds.Keywords
Funding Information
- Ardabil University of Medical Sciences (ARUMS.REC.1402.291)
This publication has 99 references indexed in Scilit:
- Antibacterial and antifungal activity of cicerfuran and related 2-arylbenzofurans and stilbenesMicrobiological Research, 2009
- Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implicationsBiochemical Society Transactions, 2007
- Design, synthesis, and discovery of stilbene derivatives based on lithospermic acid B as potent protein tyrosine phosphatase 1B inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Aza-stilbenes as potent and selective c-RAF inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Synthesis and antimicrobial activity of new (E)-4-[piperidino (4'-methylpiperidino-, morpholino-) N-alkoxy]stilbenesEuropean Journal of Medicinal Chemistry, 2006
- Antineoplastic Agents. 445. Synthesis and Evaluation of Structural Modifications of (Z)- and (E)-Combretastatin A-4Journal of Medicinal Chemistry, 2005
- Synthesis, Antitumor Evaluation, and Apoptosis-Inducing Activity of Hydroxylated (E)-StilbenesJournal of Medicinal Chemistry, 2005
- Synthesis and evaluation of cytotoxicity of stilbene analoguesArchives of Pharmacal Research, 2003
- Phytoalexins from the Vitaceae: Biosynthesis, Phytoalexin Gene Expression in Transgenic Plants, Antifungal Activity, and MetabolismJournal of Agricultural and Food Chemistry, 2002
- Design, Synthesis, and Discovery of Novel trans-Stilbene Analogues as Potent and Selective Human Cytochrome P450 1B1 InhibitorsJournal of Medicinal Chemistry, 2001